As part of the acquisition, Organon will acquire psoriasis treatment Vtama, whic...
Lupin has announced a non-exclusive patent licence agreement with Takeda for the...
Accord BioPharma received FDA approval for 420mg HERCESSI, a biosimilar to Herce...
An innovative approach to healthcare, precision medicine is a new medical model ...
Gavi has entered into an agreement with Bavarian Nordic to secure 500,000 doses ...
The US FDA has granted approval for MSD’s KEYTRUDA regimen as a first-line treat...
NanoVation will receive $600m in upfront cash and potential milestone payments, ...
Before the FDA approved AstraZeneca’s Fasenra, Nucala was the only therapy for t...
The Outsourcing in Clinical Trials New England conference will gather pharma exp...
MaxCyte has entered into a license agreement with Kamau Therapeutics, a clinical...
Sanofi has commenced the shipping of BEYFORTUS to the US for healthcare provider...
The SBTi has validated and approved India's Piramal Pharma’s near-term greenhous...
Drones are starting to play a vital role in the clinical supply chain across sub...
BMS paid $150m upfront to enter a collaborative development deal for bispecific ...
Poseida Therapeutics has received RMAT designation from the US FDA for its CAR-T...
